r.vermeulen
Submits third-party assay reports on material purchased directly. Based in Rosario.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.77%
n=9
Suppliers covered
5
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042238 | IGF-1 LR3 | Homopeptide | HOMO-2607-P1246 | PeptideMeter | 2026-Q3 | 98.34 | 6.38 | 95.0 | Laboratory-retained | 0 | PASS |
| AX-2026-041305 | Ipamorelin | WWB | WWB-2604-E3153 | VendorInvestigate | 2026-Q2 | 99.93 | 5.90 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041891 | Melanotan II | JEEP | JEEP-2604-R3923 | PeptideMeter | 2026-Q2 | 99.77 | 5.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041342 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | Janoshik | 2026-Q1 | 99.54 | 5.42 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041282 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | Kestrel | 2025-Q4 | 99.20 | 3.90 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019627 | Semaglutide | Homopeptide | HOMO-2505-N2173 | Medutest | 2025-Q4 | 98.65 | 5.88 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018537 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2411-X3830 | Nordanalyt | 2025-Q1 | 99.93 | 2.90 | 91.2 | Supplier-supplied | 1 | FAIL |
| AX-2024-004843 | BPC-157 | HJ | HJ-2407-D4137 | Medutest | 2024-Q4 | 99.78 | 7.08 | 104.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004330 | AOD-9604 | QSC | QSC-2406-G6717 | Janoshik | 2024-Q3 | 99.82 | 6.05 | — | Supplier-supplied | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| WWB | 4 | 99.74 |
| Homopeptide | 2 | n<3 |
| JEEP | 1 | n<3 |
| HJ | 1 | n<3 |
| QSC | 1 | n<3 |